Tweenvest Stocks

Turk Ilac Ve Serum Sanayi Anonim Sirketi (IBSE: TRILC)

Health Care · Pharmaceuticals · TR

TL0.94

+22.08% today · -71.5% 1Y

Turk Ilac Ve Serum Sanayi Anonim Sirketi (IBSE: TRILC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.76M.

Over the last twelve months the share price has lost 71.5%, trading between 0.71 and 4.40.

Tweenvest scores Turk Ilac Ve Serum Sanayi Anonim Sirketi across four factors: quality 56/100, value 72/100, growth 89/100. Its strongest factor is growth.

TRILC price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$19.76M
Revenue (TTM)
$114.36M
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
0.17
52-week high
TL4.40
52-week low
TL0.71
Avg volume (3M)
—
Shares outstanding
1.04B
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Biofrontera AGXTRA: B8FK$20.34M€2.99-18.75%
Nectar Lifesciences LimitedNSEI: NECLIFE$20.33MRs10.13-0.98%
Bio Medica Laboratories LimitedNSEI: BMLL$19.88MRs153.00-4.08%
SynCore Biotechnology Co.,LtdTPEX: 4192$19.80MNT$18.00-3.49%
Shenzhen Neptunus Interlong Bio-technique Company LimitedSEHK: 8329$19.67MHK$0.09+2.22%
Medico Remedies LimitedBSE: 540937$19.49MRs22.73+3.32%
BLIS Technologies LimitedNZSE: BLT$19.38MNZ$0.03-3.57%
KDventures ABOM: KDV B$19.35MSkr0.26+0.78%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.